Literature DB >> 30964743

Neonatal Fc receptor expression in macrophages is indispensable for IgG homeostasis.

Dilip K Challa1, Xiaoli Wang1, Héctor Pérez Montoyo2, Ramraj Velmurugan1, Raimund J Ober1,3,4, E Sally Ward1,4,5.   

Abstract

The maintenance of the homeostasis of immunoglobulin G (IgG) represents a fundamental aspect of humoral immunity that has direct relevance to the successful delivery of antibody-based therapeutics. The ubiquitously expressed neonatal Fc receptor (FcRn) salvages IgG from cellular degradation following pinocytic uptake into cells, conferring prolonged in vivo persistence on IgG. However, the cellular sites of FcRn function are poorly defined. Pinocytic uptake is a prerequisite for FcRn-mediated IgG salvage, prompting us to investigate the consequences of IgG uptake and catabolism by macrophages, which represent both abundant and highly pinocytic cells in the body. Site-specific deletion of FcRn to generate mice harboring FcRn-deficient macrophages results in IgG hypercatabolism and ~threefold reductions in serum IgG levels, whereas these effects were not observed in mice that lack functional FcRn in B cells and dendritic cells. Consistent with the degradative activity of FcRn-deficient macrophages, depletion of these cells in FcRn-deficient mice leads to increased persistence and serum levels of IgG. These studies demonstrate a pivotal role for FcRn-mediated salvage in compensating for the high pinocytic and degradative activities of macrophages to maintain IgG homeostasis.

Entities:  

Keywords:  FcRn; IgG homeostasis; macrophages; pharmacokinetics; pinocytosis

Mesh:

Substances:

Year:  2019        PMID: 30964743      PMCID: PMC6601554          DOI: 10.1080/19420862.2019.1602459

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  62 in total

1.  Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells.

Authors:  Jianpeng Sheng; Christiane Ruedl; Klaus Karjalainen
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

Review 2.  Vagaries of conditional gene targeting.

Authors:  Marc Schmidt-Supprian; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2007-07       Impact factor: 25.606

3.  Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis.

Authors:  Dilip K Challa; Uta Bussmeyer; Tarique Khan; Héctor P Montoyo; Pankaj Bansal; Raimund J Ober; E Sally Ward
Journal:  MAbs       Date:  2013-06-19       Impact factor: 5.857

4.  An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice.

Authors:  Kanna Kobayashi; Shuo-Wang Qiao; Masaru Yoshida; Kristi Baker; Wayne I Lencer; Richard S Blumberg
Journal:  Gastroenterology       Date:  2009-08-04       Impact factor: 22.682

Review 5.  Imaging macrophages with nanoparticles.

Authors:  Ralph Weissleder; Matthias Nahrendorf; Mikael J Pittet
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

6.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

7.  A software framework for the analysis of complex microscopy image data.

Authors:  Jerry Chao; E Sally Ward; Raimund J Ober
Journal:  IEEE Trans Inf Technol Biomed       Date:  2010-04-26

Review 8.  Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics.

Authors:  Timo Rath; Kristi Baker; Jennifer A Dumont; Robert T Peters; Haiyan Jiang; Shuo-Wang Qiao; Wayne I Lencer; Glenn F Pierce; Richard S Blumberg
Journal:  Crit Rev Biotechnol       Date:  2013-10-24       Impact factor: 8.429

9.  The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.

Authors:  Derry C Roopenian; Gregory J Christianson; Thomas J Sproule; Aaron C Brown; Shreeram Akilesh; Nadja Jung; Stefka Petkova; Lia Avanessian; Eun Young Choi; Daniel J Shaffer; Peter A Eden; Clark L Anderson
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

10.  Endothelial cells require STAT3 for protection against endotoxin-induced inflammation.

Authors:  Arihiro Kano; Michael J Wolfgang; Qian Gao; Joerg Jacoby; Gui-Xuan Chai; William Hansen; Yoshiki Iwamoto; Jordan S Pober; Richard A Flavell; Xin-Yuan Fu
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more
  18 in total

Review 1.  Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.

Authors:  E Sally Ward; Deborah Gelinas; Erwin Dreesen; Jolien Van Santbergen; Jan Terje Andersen; Nicholas J Silvestri; Joseph E Kiss; Darrell Sleep; Daniel J Rader; John J P Kastelein; Els Louagie; Gestur Vidarsson; Isabel Spriet
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

Review 2.  Deciphering albumin-directed drug delivery by imaging.

Authors:  Huiyu Hu; Jeremy Quintana; Ralph Weissleder; Sareh Parangi; Miles Miller
Journal:  Adv Drug Deliv Rev       Date:  2022-03-29       Impact factor: 17.873

3.  Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies.

Authors:  Paul R V Malik; Abdullah Hamadeh; Andrea N Edginton
Journal:  Pharm Res       Date:  2022-02-03       Impact factor: 4.200

Review 4.  The neonatal Fc receptor in cancer FcRn in cancer.

Authors:  Diana Cadena Castaneda; Guillaume Brachet; Caroline Goupille; Lobna Ouldamer; Valérie Gouilleux-Gruart
Journal:  Cancer Med       Date:  2020-05-05       Impact factor: 4.452

Review 5.  The Neonatal Fc Receptor (FcRn): A Misnomer?

Authors:  Michal Pyzik; Kine M K Sand; Jonathan J Hubbard; Jan Terje Andersen; Inger Sandlie; Richard S Blumberg
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 6.  Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance.

Authors:  Angelina Mimoun; Sandrine Delignat; Ivan Peyron; Victoria Daventure; Maxime Lecerf; Jordan D Dimitrov; Srinivas V Kaveri; Jagadeesh Bayry; Sébastien Lacroix-Desmazes
Journal:  Front Immunol       Date:  2020-05-14       Impact factor: 7.561

7.  The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.

Authors:  Souwelimatou Amadou Amani; Gillian A Lang; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2021-06-07       Impact factor: 3.441

8.  Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses.

Authors:  L J Blumberg; J E Humphries; S D Jones; L B Pearce; R Holgate; A Hearn; J Cheung; A Mahmood; B Del Tito; J S Graydon; L E Stolz; A Bitonti; S Purohit; D de Graaf; K Kacena; J T Andersen; G J Christianson; D C Roopenian; J J Hubbard; A K Gandhi; K Lasseter; M Pyzik; R S Blumberg
Journal:  Sci Adv       Date:  2019-12-18       Impact factor: 14.136

9.  Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease.

Authors:  Wei Sun; Priyanka Khare; Xiaoli Wang; Dilip K Challa; Benjamin M Greenberg; Raimund J Ober; E Sally Ward
Journal:  Mol Ther       Date:  2020-11-17       Impact factor: 11.454

Review 10.  In Translation: FcRn across the Therapeutic Spectrum.

Authors:  Timothy Qi; Yanguang Cao
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.